全文获取类型
收费全文 | 5614篇 |
免费 | 299篇 |
国内免费 | 87篇 |
专业分类
耳鼻咽喉 | 19篇 |
儿科学 | 66篇 |
妇产科学 | 43篇 |
基础医学 | 158篇 |
口腔科学 | 5篇 |
临床医学 | 267篇 |
内科学 | 287篇 |
皮肤病学 | 18篇 |
神经病学 | 243篇 |
特种医学 | 176篇 |
外科学 | 353篇 |
综合类 | 427篇 |
预防医学 | 110篇 |
眼科学 | 20篇 |
药学 | 3064篇 |
中国医学 | 188篇 |
肿瘤学 | 556篇 |
出版年
2023年 | 41篇 |
2022年 | 57篇 |
2021年 | 92篇 |
2020年 | 91篇 |
2019年 | 107篇 |
2018年 | 100篇 |
2017年 | 103篇 |
2016年 | 91篇 |
2015年 | 78篇 |
2014年 | 205篇 |
2013年 | 349篇 |
2012年 | 256篇 |
2011年 | 312篇 |
2010年 | 252篇 |
2009年 | 282篇 |
2008年 | 334篇 |
2007年 | 307篇 |
2006年 | 223篇 |
2005年 | 203篇 |
2004年 | 198篇 |
2003年 | 142篇 |
2002年 | 123篇 |
2001年 | 104篇 |
2000年 | 150篇 |
1999年 | 147篇 |
1998年 | 121篇 |
1997年 | 118篇 |
1996年 | 131篇 |
1995年 | 128篇 |
1994年 | 132篇 |
1993年 | 112篇 |
1992年 | 105篇 |
1991年 | 108篇 |
1990年 | 109篇 |
1989年 | 76篇 |
1988年 | 71篇 |
1987年 | 71篇 |
1986年 | 60篇 |
1985年 | 47篇 |
1984年 | 51篇 |
1983年 | 20篇 |
1982年 | 36篇 |
1981年 | 35篇 |
1980年 | 25篇 |
1979年 | 21篇 |
1978年 | 15篇 |
1977年 | 11篇 |
1976年 | 15篇 |
1975年 | 7篇 |
1974年 | 13篇 |
排序方式: 共有6000条查询结果,搜索用时 31 毫秒
1.
2.
《Drug discovery today》2022,27(1):280-291
Positron emission tomography (PET) is an extensively used nuclear functional imaging technique, especially for central nervous system (CNS) and oncological disorders. Currently, drug development is a lengthy and costly pursuit. Imaging with PET radiotracers could be an effective way to hasten drug discovery and advancement, because it facilitates the monitoring of key facets, such as receptor occupancy quantification, drug biodistribution, pharmacokinetic (PK) analyses, validation of target engagement, treatment monitoring, and measurement of neurotransmitter concentrations. These parameters demand careful analyses for the robust appraisal of newly formulated drugs during preclinical and clinical trials. In this review, we discuss the usage of PET imaging in radiopharmaceutical development; drug development approaches with PET imaging; and PET developments in oncological and cardiac drug discovery. 相似文献
3.
摘要:替考拉宁是治疗严重革兰阳性菌感染的首选药物之一。替考拉宁半衰期长,蛋白结合率高,属于时间依赖性药物,
临床疗效与AUC/MIC相关。替考拉宁在不同人群中的药动学参数变异大,应监测替考拉宁谷浓度进行个体化用药方案的调整。
本文通过查阅国内外文献,对替考拉宁在危重症患者、肾功能不全、低蛋白血症、儿童、老年人等特殊人群的药动学、给药方
案进行综述,以期为临床提供参考。 相似文献
4.
5.
《Saudi Pharmaceutical Journal》2020,28(3):266-273
The delivery of drugs via fast dissolving films is an effective alternative for drugs with low bioavailability when administered by other routes. This is the case of domperidone (DMP) an anti-emetic drug with low water solubility and vulnerable to extensive first-pass effect. To overcome these limitations, in this work, we designed and produced fast dissolving muco-adhesive buccal films of domperidone using varying amount polyvinylpyrrolidone (PVP K-90) using the solvent casting method. Films loaded with more than 10% of drug were not homogenous and opaque as indicated by white patches of drug in the film matrix. Formulation of DMP in the film form resulted in conversion of the drug from crystalline state to the semi-crystalline state as indicated by X-ray powder diffraction analysis. Moreover, about 40% of drug loaded within the films was released during the first five minutes compared to only about only 6.5% of pure drug in drug dissolution assays in vitro. In vivo pharmacokinetics analysis revealed that the DMP-loaded film had higher maximum plasma concentration (Cmax) and shorter time to reach Cmax (Tmax) than a commercially available tablet formulation. In conclusion, the produced DMP buccal film formulation showed high absorption rate, rapid onset of action, and improved bioavailability compared with the conventional tablet. Our findings may support the development of novel dosage forms for the transmucosal delivery of DMP for convenient, rapid, and effective treatment of nausea and vomiting. 相似文献
6.
Dandan Luo Carolyn L. Westhoff Alison B. Edelman Melissa Natavio Frank Z. Stanczyk William J. Jusko 《Contraception》2019,99(4):256-263
Objective
The objective was to evaluate the pharmacokinetics (PKs) of levonorgestrel (LNG)-containing combined oral contraceptives (COCs) in obese women.Study design
We pooled and reanalyzed data from 89 women with different body mass index (BMI) categories from four clinical studies. The LNG and ethinyl estradiol (EE) PKs were analyzed utilizing a zero-order absorption (K0), two-compartment PK model to evaluate key PK parameters in relation to a range of weights, BMI and body surface area (BSA).Results
Increasing of body habitus metrics is correlated with decreasing Cmax (p<.0001) and AUCτ (p<.05) for both LNG and EE, but no correlation was found for Cmin (p≥.17). Increasing weight and BMI were associated with a modest increase (p≤.056) of clearance (CL) and appreciable increases of central volume (V1, p<.05), distribution clearance (CLd, p≤.001) and peripheral volume (V2, p<.0001) for LNG. For EE, increases in CL (p≤.009) were found with greater weight, BMI and BSA. Values of V1, CLd and V2 also increased (p<.0001) in obese subjects. The half-life and steady-state volume were greater among obese women (p<.0001) for both LNG and EE. LNG and EE PK parameters correlated well (p≤.006 for all), indicating that individual subject physiology affected both drugs similarly.Conclusions
The primary effects of obesity on LNG and EE were a modest increase in CL and a marked increase in distribution parameters. We observed no obesity-related differences in trough LNG and EE concentrations.Implications
This population PK analysis demonstrated reduced systemic exposure to LNG/EE oral contraceptives in obese subjects (Cmax and AUCτ); these particular differences are unlikely to lower contraceptive effectiveness among obese women who are correctly using LNG-containing contraceptives. 相似文献7.
《Digestive and liver disease》2019,51(8):1112-1116
BackgroundThiopurines seem to have positive effect on the pharmacokinetics of anti-tumor necrosis factor biologics. It has been suggested that a reduced dose of thiopurines is sufficient to achieve this synergism.AimsTo assess the differences of infliximab (IFX) trough levels according to the dose of concomitantly used azathioprine (AZA).Patients & methodsAll IBD patients treated with IFX (Remicade®) in two IBD centres between November 2015 and April 2017 were eligible. Infliximab trough levels were assessed by ELISA (Ridascreen®, R-Biopharm). The differences in IFX trough levels according to AZA dose were analyzed statistically.ResultsIn total, 125 patients were included, 42 pts (33.6%) on infliximab monotherapy, 83 pts (66.4%) using combined immune suppression.The respective median IFX levels according to AZA dose were as follows: group 1 (no concomitant AZA) 2.83 μg/ml (range 0–12); group 2 (AZA dose less than 1 mg/kg) 4.91 μg/ml (range 0.09–15.36); group 3 (AZA dose 1 < 2 mg/kg) 5.67 (range 0.16–16.97); group 4 (AZA dose above 2 mg/kg) 7.53 μg/ml (range 1.15–8.73). The differences in IFX trough levels between the respective groups according to AZA dose were statistically significant (p = 0.0159).ConclusionThe positive effect of azathioprine on infliximab levels seems to be dependent on the dose of concomitantly used azathioprine. 相似文献
8.
9.
10.
Primaquine (PQ) is a racemic drug used in treatment of malaria for six decades. Recent studies suggest that the two enantiomers of PQ are differentially metabolized in animals, and this results in different pharmacological and toxicological profiles. The current study characterizes the pharmacokinetic (PK) properties, metabolism and tolerability of the individual enantiomers of PQ in healthy human volunteers with normal glucose-6-phosphate dehydrogenase (G6PD) activity. Two cohorts (at two dose levels), each with 18 subjects, participated in three study arms in a crossover fashion: a single dose of the (−)-R enantiomer (RPQ), a single dose of the (+)-S enantiomer (SPQ), and a single dose of racemic PQ (RSPQ). PQ and its key metabolites carboxyprimaquine (cPQ) and PQ-N-carbamoyl glucuronide (PQ-N-CG) were analyzed. Clear differences were observed in PK and metabolism of the two enantiomers. Relative PQ exposure was higher with SPQ as compared to RPQ. PQ maximum plasma concentration (Cmax) and area under the plasma concentration-time curve were higher for SPQ, while the apparent volume of distribution and total body clearance were higher for RPQ. Metabolism of the two enantiomers showed dramatic differences: plasma PQ-N-CG was derived solely from SPQ, while RPQ was much more efficiently converted to cPQ than was SPQ. Cmax of cPQ and PQ-N-CG were 10 and 2 times higher, respectively, than the parent drugs. The study demonstrates that the PK properties of PQ enantiomers show clear differences, and metabolism is highly enantioselective. Such differences in metabolism suggest potentially distinct toxicity profiles in multi-dose regimens, especially in G6PD-deficient subjects. 相似文献